This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Lynn H. Orr, Jr, MD; Elbert Rudisill, Jr, MD; Richard Brodkin, MD; Robert W. Hamilton, MD

Arch Intern Med. 1978;138(5):793-794.

Abstract
Doxycycline has been considered a safe broad-spectrum antibiotic for patients with renal failure. Although doxycycline possesses many of the metabolic properties of the tetracycline group, toxic blood levels usually do not occur because of the drug's unique extrarenal route of excretion. We report here a patient with stable chronic renal failure whose renal function acutely and reversibly deteriorated coincident with a 14-day course of doxycycline. Review of the literature suggests that occasional patients may have impairment of the nonrenal excretory pathway for doxycycline. We speculate that these patients are at risk for developing nephrotoxic levels of this antibiotic.

(Arch Intern Med 138:793:794, 1978)

Author Affiliations
From the Nephrology Division, Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, NC.

Footnotes
Accepted for publication May 24, 1977.

Reprint requests to Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, NC 27103 (Dr Hamilton).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Doxycycline Revisited
Joshi and Miller
Arch Intern Med 1997;157:1421-1428.
ABSTRACT  

Lithium Carbonate Toxicity: Acneform Eruption and Other Manifestations
Heng
Arch Dermatol 1982;118:246-248.
ABSTRACT  

Drug Therapy in Renal Failure: Dosing Guidelines for Adults: Part I: Antimicrobial Agents, Analgesics
BENNETT et al.
ANN INTERN MED 1980;93:62-89.
ABSTRACT